CT features of radiation-induced lung injuries can show the prognosis after stereotactic ablative radiotherapy in early-stage non-small cell lung cancer

Author:

Wang Fang1,Wang Lin2,Yang Hong1,chen Wujie1,Ruan Lei1,Xu Yujin1,Jiang Haitao1

Affiliation:

1. Zhejiang Cancer Hospital

2. Shaoxing UniversitySchool of Medicine

Abstract

Abstract Objective To investigate the correlation between peritumoral radiation-induced lung injuries and prognosis of early non-small cell lung cancer after stereotactic ablative radiotherapy (SABR). Methods Clinical data and follow-up imaging data of patients with early NSCLC who received SABR treatment in Department of Thoracic Radiotherapy of Zhejiang Cancer Hospital from January 2012 to December 2018 were retrospectively collected, and the Progression Free Survival (PFS) was calculated. CT features of peritumoral radiation-induced lung injuries were observed by 3 radiologists with more than 10–15 years of experience. CT features of peritumoral radiation-induced lung injuries were divided into 3 types. Type 1 was diffuse consolidation around the tumor with the tumor boundary covered. Type 2 is the diffuse ground glass shadow around the tumor, which is distributed in the range of more than 180 degrees around the tumor. Type 3 is the patchy ground glass shadow surrounding the tumor within a range of less than 180 degrees. Log-rank test was used to analyze the correlation between CT features of radiation-induced lung injuries and PFS rate of NSCLC after SABR. Independent influencing factors of PFS rate were analyzed by COX multivariate regression. Results 5-year PFS rate corresponding to CT features of peritumoral radiation-induced lung injuries 3–5 months after SABR in early lung cancer were type 1:68.1%; Type 2:73.1%; Type 3:35.3%; there was a statistical difference between the CT features of three types of peritumoral radiation-induced lung injuries (p = 0.006). The 5-year PFS rate corresponding to the CT features of peritumoral radiation-induced lung injuries 6–8 months after SABR were type 1:69.5%; Type 2:50.9%; Type 3:36.1%; there was statistical difference between the CT features of three types of peritumoral radiation-induced lung injuries (p = 0.025). COX multivariate regression analysis showed that the CT features of peritumoral radiation-induced lung injuries were independent factors influencing PFS rate (at 6–8 months follow-up after radiotherapy (p = 0.041). Conclusions CT features of peritumoral radiation-induced lung injuries can predict the recurrence risk of early non-small cell lung cancer after SABR, and the type of CT features at 6–8 months after SABR was an independent predictor of recurrence risk.

Publisher

Research Square Platform LLC

Reference7 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Global Cancer Statistics, Cancer J, Clin WJ, Howington J, Feigenberg S, Movsas B, Pisters K. Treatment of Non-Small Cell Lung Cancer Stage I and Stage II: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest (2007) 132: 234–242. doi: 10.1378/chest.07-1378 [3] Stanic, Paulus S, Timmerman R, Michalski RD, Barriger JM, Bezjak RB A, No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early-stage peripheral non-small cell lung cancer: an analysis of RTOG 0236. Int J Radiat Oncol Biol Phys (2014) 88: 1092–1099. doi:, Schipper X, Kidwell M, Lin K, Reddy J, Ren R Y, Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis. Int J Radiat Oncol Biol Phys (2014) 90: 603–611. doi: 10.1016/j.ijrobp.2014.05.055 [5] Ma L, Xiang J et al. Clinical outcomes of video-assisted thoracic surgery and stereotactic body radiation therapy for early-stage non-small cell lung cancer: A meta-analysis. Thorac Cancer (2016) 7: 442–451. doi: 10.1111/1759-7714.12352.

2. Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a retrospective analysis. Lancet Oncol (, Chang JY, Liu H, Balter P, Komaki R, Liao Z, Welsh J, Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer. Radiat Oncol (2012) 7: 152. doi:, Hope IS, Guckenberger AJ, Kestin M, Werner-Wasik LL, Yan M D, A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy. J Thorac Oncol (2012) 7: 1382–1393. doi: 10.1097/JTO.0b013e318260e00d [9], Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, Outcome in a prospective phase II trial of medically inoperable stageInon-small-cell lung cancer patients treated with stereotactic body radiotherapy. Clin Oncol (2009) 27: 3290–3296. doi: 10.1200/JCO.2008.21.5681 [10] Grills IS, Mangona, Welsh VS, Chmielewski R, Mcinerney G, Martin E et al. S, Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol (2010) 28: 928–935. doi: 10.1016/j.ijrobp.2009.07.155.

3. A combined predictive model based on radiomics features and clinical factors for disease progression in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy;Yang H;Front Oncol,2022

4. Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques;Palma DA;Int J Radiat Oncol Biol Phys,2011

5. Long-term results of RTOG 0236: a phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I non-small cell lung cancer;Timmerman RD;Int J RadiatOncol,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3